Skip to main content


Sana Symposium 2023
Official Meeting of the Psychedelic Medicine Association
Psychedelics Education for Mental Health & Addiction Professionals

Sa · na
(v) to heal.

Welcome to Sana Symposium. We are your premier resource for staying up to date on the latest clinical advances in research breakthroughs and expert-guided strategies in the field of psychedelic therapies.

Join the movement - the field of psychedelics is evolving quickly. We invite you to join our global network of motivated clinicians and renowned experts to participate in this unique, online, educational experience. Get ready to immerse yourself in diverse perspectives about the successful practice of psychedelic therapies across psychiatry, psychotherapy, and addiction treatment. Discover promising results in utilizing this new treatment option to treat mental health disorders including major depression, anxiety, and PTSD.

Now is the time to prepare you and your practice for this next wave of revolutionary treatment. Registration is open!

Rakesh Jain, MD, MPH

With session recordings available on-demand, gain the confidence and expertise to effectively guide patients interested in psychedelic therapies, and set the stage for a smooth transition of this new treatment option into your practice.

Motivated Clinicians
Innovative Sessions
Practice-Changing Days
Who Should Attend?

Sana Symposium is designed and accredited for all members of the mental health and addiction treatment community. A virtual environment where you can expand your perspective, explore innovative ideas, and take part in a diverse program where efficiency and effectiveness are paramount.

Nurse Practitioners
Physician Assistants
Primary Care Physicians
Social Workers
Students, Residents, and Fellows
Other Mental Health & Addiction Professionals
Meet our Steering Committee

Sana Symposium is partnering with nine world-renowned educators, practitioners, and research trailblazers in the field of psychedelics to make the 2023 conference an insightful, practical, and impactful educational experience.

Kwasi Adusei, DNP, PMHNP
Senior Prescriber at Journey Clinical
Robin Carhart-Harris, PhD
Director, Centre for Psychedelic Research, Imperial College London
Rick Doblin, PhD
Founder and Executive Director, Multidisciplinary Association for Psychedelic Studies (MAPS)
Rakesh Jain, MD, MPH
Clinical Professor, Department of Psychiatry, Texas Tech Health Sciences Center School of Medicine, Midland, Texas
Saundra Jain, MA, PsyD, LPC
Adjunct Clinical Affiliate, University of Texas at Austin School of Nursing; Private Practice, Austin, Texas
Lynn Marie Morski, MD, ESQ
President, Psychedelic Medicine Association
Andrew Penn, RN, MS, NP, CNS, APRN-BC
Associate Clinical Professor, University of California, San Francisco, California
Charles Raison, MD
Director of Clinical and Translational Research, Usona Institute
Rosalind Watts, PhD
Founder, ACER Integration
Psychedelics, when used wisely, have the potential to heal us, help inspire us, and perhaps even save us."

Rick Doblin, PhD
Founder & Executive Director, Multidisciplinary Association for Psychedelic Studies

Psychedelic agents have a long history of human use, almost always reserved for sacred rituals. The reason for that is because they induced very profound changes in perception, thought, and feeling."

Charles Raison, MD
Chair, Clinical Advisory Board, Usona

In Partnership with